{
    "id": "dbpedia_139_2",
    "rank": 28,
    "data": {
        "url": "https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.13809",
        "read_more_link": "",
        "language": "en",
        "title": "2024 Alzheimer's disease facts and figures",
        "top_image": "https://alz-journals.onlinelibrary.wiley.com/cms/asset/8e8201eb-cb18-4c87-a794-a85c570d0eb0/alz.v20.5.cover.jpg?trick=1723204437791",
        "meta_img": "https://alz-journals.onlinelibrary.wiley.com/cms/asset/8e8201eb-cb18-4c87-a794-a85c570d0eb0/alz.v20.5.cover.jpg?trick=1723204437791",
        "images": [
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/alz-journals/logo-header-1675266282753.png",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/alz-journals/mobilehublogo-1675266282707.png",
            "https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&sz=728x90&tile=1&c=$random",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/journal-banners/15525279-1699030868153.jpg",
            "https://alz-journals.onlinelibrary.wiley.com/specs/products/acropolis/pericles/releasedAssets/images/pdf-icon-169a2eb30e52100e76dfa5f4b66998e6.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/59bd9cbd-57b0-4719-8306-857373683487/alz13809-fig-0001-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/1bb9020e-0db1-4158-b31b-1d3214fdaa00/alz13809-fig-0002-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/c2f7c485-0eba-40ab-9159-035e8af93dcc/alz13809-fig-0003-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/464544d6-c0de-47d4-8f4a-f9b902957692/alz13809-fig-0004-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/0d345e6a-ea91-428b-8605-9429a90a0d6f/alz13809-fig-0005-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/1e2481ed-7d54-473a-804a-af9a065899b9/alz13809-fig-0006-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/cd1b6e8a-bf10-4a60-83f0-04be2de60833/alz13809-fig-0007-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/0a8e2c2d-7e94-4b79-a1e2-c5b15517c589/alz13809-fig-0008-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/92287e2f-bdcc-4ffb-be92-0d1a9a81cccb/alz13809-fig-0009-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/3cabc491-dd5a-4314-8cb0-ca9a8ee4c1b6/alz13809-fig-0010-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/48bb393c-fa87-4106-96a5-d2267f45e27b/alz13809-fig-0011-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/53026a9d-70f1-4e86-a616-d940c936c39e/alz13809-fig-0012-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/a6b70397-2999-4f9f-ac9e-606bd328618a/alz13809-fig-0013-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/19e2e58e-1967-44d8-8256-3e6cb60a0342/alz13809-fig-0014-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/cba08bd4-9043-47fb-bab3-dfc1c1fc2a22/alz13809-fig-0015-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/c2f35831-2ac2-4f36-b372-8394d32c6236/alz13809-fig-0016-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/b22104c2-f962-4b16-bb55-40b69cbfaf90/alz13809-fig-0017-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/b5a9799c-bf50-45a7-a1d5-db2976eb91dc/alz13809-fig-0018-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/783dffbb-f890-4d88-b37a-0ae4e7ecb070/alz13809-fig-0019-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/5371bddf-db22-428d-8ec8-2c3c81ba532d/alz13809-fig-0020-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/a2265231-ae8f-417b-b816-08aeed3672e9/alz13809-fig-0021-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/d025e197-c312-4aa2-9b40-2a5ade2f1d03/alz13809-fig-0022-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/b9556149-89df-4be6-87a4-229067035d3b/alz13809-fig-0023-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/5d5d4086-d7c0-48ac-94ac-f36694a86a0a/alz13809-fig-0024-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/5c180ccf-0253-41fc-85bb-e07487616834/alz13809-fig-0025-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/6f6ccf04-b055-45e0-a25a-3aebbc602b54/alz13809-fig-0026-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/80771d76-0767-421c-a699-a58065693190/alz13809-fig-0027-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/22b51530-fdd8-40ea-aafb-131452a77456/alz13809-fig-0028-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/e9f0dc4b-d251-4dec-982d-131eaad3da45/alz13809-fig-0029-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/d880892b-a28d-41b9-9953-92985276f52e/alz13809-fig-0030-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/36d9e7c7-92b2-4139-ae47-a21a481c612e/alz13809-fig-0031-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/848f533c-c375-4491-9475-67c0c13a9657/alz13809-fig-0032-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/47917dda-6221-4fb0-b816-f0811b2f4544/alz13809-fig-0033-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/beef4cd4-85a1-408f-ac36-c840d49a8c6d/alz13809-fig-0034-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/54bb6ce2-8dca-42c2-bb6c-9b40efb7fc18/alz13809-fig-0035-m.png",
            "https://alz-journals.onlinelibrary.wiley.com/cms/asset/8e8201eb-cb18-4c87-a794-a85c570d0eb0/alz.v20.5.cover.jpg",
            "https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&sz=160x600|160x320|160x160|120x600&tile=2&c=$random",
            "https://alz-journals.onlinelibrary.wiley.com/specs/products/acropolis/pericles/releasedAssets/images/spinner-1ffd60b3aabe5b09bc98c48345208fd9.gif",
            "https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&sz=160x600|160x320|160x160|120x600&tile=2&c=$random",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/alz-journals/logo-footer-1675266282733.png",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/tmp-images/footer-logo-wiley-1510029248417.png",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/pericles/logo-header-1690978619437.png",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/pericles/logo-header-1690978619437.png",
            "https://alz-journals.onlinelibrary.wiley.com/pb-assets/hub-assets/pericles/logo-header-1690978619437.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Guterman S",
            "Werner RM",
            "Emanuel EJ",
            "Pham HH",
            "Navathe AS",
            "Baumgart M",
            "Brookmeyer R",
            "Gray S",
            "Kawas C",
            "Fortea J"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "This article describes the public health impact of Alzheimer's disease (AD), including prevalence and incidence, mortality and morbidity, use and costs of care and the ramifications of AD for family ...",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "Alzheimer’s Association",
        "canonical_link": "https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13809",
        "text": "REFERENCES\n\n1Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid ß deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurol. 2013; 12(4): 357-367.\n\n2Reiman EM, Quiroz YT, Fleisher AS, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 2012; 11(2): 1048-1056.\n\n3Jack CR, Lowe VJ, Weigand SD, et al. Serial PiB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain. 2009; 132: 1355-1365.\n\n4Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012; 367(9): 795-804.\n\n5Gordon BA, Blazey TM, Su Y, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: A longitudinal study. Lancet Neurol. 2018; 17(3): 241-250.\n\n6Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011; 70(11): 960-969.\n\n7Quiroz YT, Zetterberg H, Reiman EM, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional and longitudinal cohort study. Lancet Neuro. 2020; 19(6): 513-521.\n\n8Barthelemy N, Joseph-Mathurin N, Gordon BA, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nat Med. 2020; 26: 398-407.\n\n9Byard RW, Langlois NEI. Wandering dementia: A syndrome with forensic implications. J Forensic Sci. 2019; 64(2): 443-445.\n\n10Tom SE, Hubbard RA, Crane PK, et al. Characterization of dementia and Alzheimer's disease in an older population: Updated incidence and life expectancy with and without dementia. Am J Public Health. 2015; 105(2): 408-413.\n\n11Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. Alzheimer disease and mortality: A 15-year epidemiological study. Arch Neurol. 2005; 62(5): 779-784.\n\n12Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord. 2005; 19(4): 178-183.\n\n13Brookmeyer R, Corrada MM, Curriero FC, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002; 59(11): 1764-1767.\n\n14Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004; 140(7): 501-509.\n\n15Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y. Survival in Alzheimer disease: A multiethnic, population-based study of incident cases. Neurology. 2008; 71(19): 1489-1495.\n\n16Xie J, Brayne C, Matthews FE. Survival times in people with dementia: Analysis from a population based cohort study with 14-year follow-up. BMJ. 2008; 336(7638): 258-262.\n\n17Brodaty H, Seeher K, Gibson L. Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr. 2012; 24(7): 1034-1045.\n\n18Todd S, Barr S, Roberts M, Passmore AP. Survival in dementia and predictors of mortality: A review. Int J Geriatr Psychiatry. 2013; 28(11): 1109-1124.\n\n19 World Health Organization. Dementia: Key facts. Accessed October 10, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/dementia\n\n20Smith AD, Smith SM, de Jager, CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. Plos One. 2010; 5(9):e12244.\n\n21Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017; 134(2): 171-186.\n\n22Brenowitz WD, Hubbard RA, Keene CD, et al. Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. Alzheimers Dement. 2017; 13(6): 654-662.\n\n23 National Institute on Aging. What are frontotemporal disorders? Accessed December 16, 2023. Available at: https://www.nia.nih.gov/health/what-are-frontotemporal-disorders\n\n24Hogan DB, Jette N, Fiest KM, et al. The prevalence and incidence of frontotemporal dementia: A systematic review. Can J Neurol Sci. 2016; 43(suppl): S96-109.\n\n25Amador-Ortiz C, Ahmed Z, Zehr C, Dickson DW. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration. Acta Neuropathol. 2007; 113(3): 245-252.\n\n26Kane JPM, Surendranathan A, Bentley A, Thomas AJ, et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018 Feb 15; 10(1): 19.\n\n27De Reuck J, Maurage CA, Deramecourt V, et al. Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: A neuropathological study. Folia Neuropathol. 2018; 56(2): 81-87.\n\n28James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012; 307(17): 1798-1800.\n\n29Stojkovska I, Krainc D, Mazzulli JR. Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease. Cell Tissue Res. 2018; 373(1): 51-60.\n\n30Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 2005; 20(10): 1255.\n\n31Kawas CH, Kim RC, Sonnen JA, Bullain SS, Trieu T, Corrada MM. Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study. Neurology. 2015; 85(6): 535-542.\n\n32Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: How to move forward? Neurology. 2009; 72: 368-374.\n\n33Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007; 69: 2197-2204.\n\n34Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009; 66(2): 200-208.\n\n35Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. J Neurol Sci. 2007; 257(1-2): 80-87.\n\n36Jellinger KA. The enigma of mixed dementia. Alzheimers Dement. 2007; 3(1): 40-53.\n\n37Boyle PA, Lei Y, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018; 83(1): 74-83.\n\n38Boyle PA, Yu L, Leurgans SE, et al. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019; 85(1): 114-124.\n\n39Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol. 2010; 119: 421-433.\n\n40Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3): 280-292.\n\n41Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3): 270-279.\n\n42McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3): 263-269.\n\n43Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3): 257-262.\n\n44Vermunt L, Sikkes SAM, van den Hout A, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 2019; 15: 888-898.\n\n45Sperling RA, Donohue MC, Raman R, et al. Association of factors with elevated amyloid burden in clinically normal older individuals. JAMA Neurol. 2020; 77(6): 735-745.\n\n46Olsson B, Lautner R, Andreasson U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: A systematic review and meta-analysis. Lancet Neurol. 2016; 15(7): 673-684.\n\n47Hunt A, Schonknecht P, Henze M, Seidl U, Haberkorn U, Schroder J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psych Res: Neuroimaging. 2007; 155: 147-154.\n\n48Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006; 66: 1837-1844.\n\n49Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol. 2003; 62: 1087-1095.\n\n50Grontvedt GR, Schroder TN, Sando SB, White L, Brathen G, Doeller CF. Alzheimer's disease. Curr Bio. 2018; 28: PR645-PR649.\n\n51Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment. Neurology. 2018; 90(3): 126-135.\n\n52Ward A, Tardiff S, Dye C, Arrighi HM. Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: A systematic review of the literature. Dement Geriatr Cogn Disord Extra. 2013; 3(1): 320-332.\n\n53Canevelli M, Grande G, Lacorte E, et al. Spontaneous reversion of mild cognitive impairment to normal cognition: A systematic review of literature and meta-analysis. J Am Med Dir Assoc. 2016; 17(10): 943-948.\n\n54 Social Security Administration. Minimizing the risk of scams for people living with dementia. Accessed October 11, 2023. Available at: https://blog.ssa.gov/minimizing-the-risk-of-scams-for-people-living-with-dementia/#:~:text=People%20living%20with%20dementia%20are,struggle%20to%20make%20financial%20decisions\n\n55 Memory and Aging Center, UCSF Weill Institute for Neurosciences. Executive functions. Accessed October 11, 2023. Available at: https://memory.ucsf.edu/symptoms/executive-functions\n\n56Heerema E. How executive functioning Is affected by dementia. Verywell Health. Accessed October 30, 2023. Available at: https://www.verywellhealth.com/executive-functioning-alzheimers-98596\n\n57Beshir SA, Aadithsoorya AM, Parveen A, Goh SSL, Hussain N, Menon VB. Aducanumab therapy to treat Alzheimer's disease: A narrative review. Int J Alzheimers Dis. 2022; 2022:9343514.\n\n58van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2023; 388: 9-21.\n\n59Cummings J, Apostolova L, Rabinovici GD, et al. Lecanemab: Appropriate use recommendations. J Prev Alzheimers Dis. 2023; 10(3): 362-377.\n\n60Cummings J, Aisen P, Apostolova LG, Atri A, Salloway S, Weiner M. Aducanumab: Appropriate use recommendations. J Prev Alz Dis. 2021; 4(8): 398-410.\n\n61Cummings J, Rabinovici GD, Atri A. et al. Aducanumab: Appropriate Use Recommendations Update. J Prev Alzheimers Dis. 2022; 9: 221-230.\n\n62Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer's disease drug development timeline: 2023. Alzheimers Dement: TRCI 2023. doi:10.1002/trc2.12385\n\n63Lim MM, Gerstner JR, Holtzman DM. The sleep-wake cycle and Alzheimer's disease: What do we know? Neurodegener Dis Manag. 2014; 4(5): 351-362.\n\n64Lloret M-A, Cervera-Ferri A, Nepomuceno M, Monllor P, Esteve D, Lloret A. Is sleep disruption a cause or consequence of Alzheimer's disease? Reviewing its possible role as a biomarker. Int J Mol Sci. 2020; 21: 1168.\n\n65Rose KM, Fagin CM, Lorenz R. Sleep Disturbances in Dementia: What They Are and What To Do. J Gerontol Nurs. 2010; 36(5): 9-14.\n\n66Van der Mussele S, Le Bastard N, et al. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia. Aging Ment Health. 2015; 19(3): 247-257.\n\n67Watt JA, Goodarzi Z, Veroniki AA, et al. Comparative efficacy of interventions for aggressive and agitated behaviors in dementia. Ann Internal Med. 2019; 171(9): 633-642.\n\n68Ralph SJ, Espinet AJ. Increased all-cause mortality by antipsychotic drugs: Updated review and meta-analysis in dementia and general mental health care. J Alzheimers Dis Rep. 2018; 2: 1-26.\n\n69Maust DT, Kim HM, Seyfried LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015; 72: 438-445.\n\n70Hebert LE, Bienias JL, Aggarwal NT, et al. Change in risk of Alzheimer disease over time. Neurology. 2010; 75: 786-791.\n\n71 National Institute on Aging. Accessed December 15, 2023. Available at: https://www.nia.nih.gov/health/what-causes-alzheimers-disease\n\n72Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43: 1467-1472.\n\n73Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA. 1997; 278: 1349-1356.\n\n74Green RC, Cupples LA, Go R, et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002; 287(3): 329-336.\n\n75Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer's disease: A population-based, case-control study. Ann Neurol. 1993; 33(3): 258-266.\n\n76Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y. Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. Arch Neurol. 1991; 48(3): 269-273.\n\n77Lautenschlager NT, Cupples LA, Rao VS, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE Study: What is in store for the oldest old? Neurology. 1996; 46(3): 641-650.\n\n78Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 Census. Neurology. 2013; 80(19): 1778-1783.\n\n79Nelson PT, Head E, Schmitt FA, et al. Alzheimer's disease is not “brain aging”: Neuropathological, genetic, and epidemiological human studies. Acta Neuropathol. 2011; 121: 571-587.\n\n80Bellenguez C, Küçükali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet. 2022; 54: 412-436.\n\n81Loy CT, Schofield PR, Turner AM, Kwok JBJ. Genetics of dementia. Lancet. 2014; 383: 828-840.\n\n82Qian J, Wolters FJ, Beiser A, et al. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. PLoS Med. 2017; 14(3):e1002254.\n\n83Spinney L. Alzheimer's disease: The forgetting gene. Nature. 2014; 510(7503): 26-28.\n\n84Ward A, Crean S, Mercaldi CJ, et al. Prevalence of apolipoprotein e4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: A systematic review and meta-analysis. Neuroepidemiology. 2012; 38: 1-17.\n\n85Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med. 1998; 338: 506-511.\n\n86Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status. Arch Neurol. 2003; 60(2): 185-189.\n\n87Tang M, Stern Y, Marder K, et al. The APOE-e4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998; 279: 751-755.\n\n88Weuve J, Barnes LL, Mendes de Leon CF, et al. Cognitive aging in black and white Americans: Cognition, cognitive decline, and incidence of Alzheimer disease dementia. Epidemiology. 2018; 29(1): 151-159.\n\n89Hendrie HC, Murrell J, Baiyewu O, et al. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba. Int Psychogeriatr. 2014; 26(6): 977-985.\n\n90Reitz C, Jun G, Naj A, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E epsilon 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013; 309(14): 1483-1492.\n\n91Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 2017; 74(10): 1246-1254.\n\n92Bakulski KM, Vadari HS, Faul JD, et al. Cumulative genetic risk and APOE «4 are independently associated with dementia status in a multiethnic, population-based cohort. Neurol Genet. 2021; 7:e576.\n\n93Rajan KB, Barnes LL, Wilson RS, et al. Racial differences in the association between apolipoprotein E risk alleles and overall and total cardiovascular mortality over 18 years. JAGS. 2017; 65: 2425-2430.\n\n94Kataoka S, Robbins DC, Cowan LD, et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 1996; 16: 918-925.\n\n95Le Guen Y, Raulin AC, Logue MW, et al. Association of African ancestry-specific APOE missense variant R145C with risk of Alzheimer disease. JAMA. 2023; 329(7): 551-560.\n\n96Granot-Hershkovitz E, Tarraf W, Kurniansyah N, et al. APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos-investigation of neurocognitive aging (HCHS/SOL). Alzheimer's Dement. 2021; 17: 466-474.\n\n97Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol. 2010; 9(6): 623-633.\n\n98 National Down Syndrome Society. Alzheimer's Disease and Down Syndrome. Accessed December 15, 2023. Available at: https://www.ndss.org/resources/alzheimers/\n\n99Fortea J, Vilaplana E, Carmona-Iragui M, et al. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: A cross-sectional study. Lancet. 2020; 395(10242): 1988-1997.\n\n100Fortea J, Zaman SH, Hartley S, Rafii MS, Head E, Carmona-Iragui M. Alzheimer's disease associated with Down syndrome: A genetic form of dementia. Lancet Neurol. 2021; 20(11): 930-942.\n\n101Hithersay R, Startin CM, Hamburg S, et al. Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol. 2019; 76(2): 152-160.\n\n102Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010; 23(4): 213-227.\n\n103Goldman JS, Hahn SE, Bird T. Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011; 13: 597-605.\n\n104Lopera F, Marino C, Chandrahas AS, et al. Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man. Nat Med. 2023 May; 29(5): 1243-1252.\n\n105Arboleda-Velasquez JF, Lopera F, O'Hare M, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019; 25(11): 1680-1683.\n\n106Wolters FJ, van der Lee SJ, Koudstaal PJ, et al. Parental family history of dementia in relation to subclinical brain disease and dementia risk. Neurology. 2017; 88: 1642-1649.\n\n107Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020; 396(10248): 413-446.\n\n108Rosenwohl-Mack A, Yaffe K, Carrasco A, Hoffmann CM, Barnes DE. Risk factors associated with Alzheimer disease and related dementias by sex and race and ethnicity in the US. JAMA Neurol. 2022; 79(6): 584-591.\n\n109 World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. https://www.who.int/publications/i/item/risk-reduction-of-cognitive-decline-and-dementia\n\n110 Institute of Medicine. Cognitive Aging: Progress in Understanding and Opportunity for Action. Washington, D.C.: The National Academies Press; 2015.\n\n111James BD, Bennett DA. Causes and patterns of dementia: An update in the era of redefining Alzheimer's disease. Ann Rev Public Health. 2019; 40: 65-84.\n\n112Mergenthaler P, Lindauer U, GA Dienel, Meisel A. Sugar for the brain: The role of glucose in physiological and pathological brain function. Trends Neurosci. 2013; 36(10): 587-597.\n\n113Kuźma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ. Stroke and dementia risk: A systematic review and meta-analysis. Alzheimers Dement. 2018; 14(11): 1416-1426.\n\n114Samieri C, Perier MC, Gaye B, et al. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA. 2018; 320(7): 657-664.\n\n115Rönnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord. 2011; 31(6): 460-466.\n\n116Abell JG, Kivimäki M, Dugravot A, et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: Role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018; 39(33): 3119-3125.\n\n117Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77: 461-468.\n\n118Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. Diabetes Investig. 2013; 4(6): 640-650.\n\n119Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: The confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013; 35(1): 152-160.\n\n120Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011; 7(3): 137-152.\n\n121Johnson AL, Nystrom NC, Piper ME, et al. Cigarette smoking status, cigarette exposure, and duration of abstinence predicting incident dementia and death: A multistate model approach. J Alzheimers Dis. 2021; 80(3): 1013-1023.\n\n122Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008; 8: 36.\n\n123Ogino E, Manly JJ, Schupf N, Mayeux R, Gu Y. Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults. Alzheimers Dement. 2019; 15(12): 1603-1611.\n\n124Najar J, Ostling S, Gudmundsson P, et al. Cognitive and physical activity and dementia: A 44-year longitudinal population study of women. Neurology. 2019; 92(12): e1322-e1330.\n\n125Buchman AS, Yu L, Wilson RS, et al. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019; 92(8): e811-e822.\n\n126Tan ZS, Spartano NL, Beiser AS, et al. Physical activity, brain volume, and dementia risk: The Framingham Study. J Gerontol A Biol Sci Med Sci. 2017; 72: 789-795.\n\n127Stephen R, Hongistro K, Solomon A, Lonnroos E. Physical activity and Alzheimer's disease: A systematic review. J Gerontol A Biol Sci Med Sci. 2017; 72(6): 733-739.\n\n128Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health. 2014; 14: 510.\n\n129Guure CB, Ibrahim NA, Adam MB, Said SM. Impact of physical activity on cognitive decline, dementia, and its subtypes: Meta-analysis of prospective studies. Biomed Res Int. 2017; 2017:9016924.\n\n130Jensen CS, Simonsen AH, Siersma V, et al. Patients with Alzheimer's disease who carry the APOE e4 allele benefit more from physical exercise. TRCI. 2019; 5: 99-106.\n\n131Felisatti F, Gonneaud J, Palix C, et al. Role of cardiovascular risk factors on the association between physical activity and brain integrity markers in older adults. Neurology. 2022; 98(20): e2023-e2035.\n\n132Casaletto K, Ramos-Miguel A, VandeBunte A, et al. Late-life physical activity relates to brain tissue synaptic integrity markers in older adults. Alzheimers Dement. 2022; 18(11): 2023-2035.\n\n133Nguyen S, LaCroix AZ, Hayden KM, et al. Accelerometer-measured physical activity and sitting with incident mild cognitive impairment or probable dementia among older women. Alzheimers Dement. 2023; doi:10.1002/alz.12908\n\n134Hardman RJ, Kennedy G, Macpherson H, Scholey AB, Pipingas A. Adherence to a Mediterranean-style diet and effects on cognition in adults: A qualitative evaluation and systematic review of longitudinal and prospective trials. Front Nutr. 2016; 3: 22.\n\n135Lourida I, Soni M, Thompson-Coon J, et al. Mediterranean diet, cognitive function, and dementia: A systematic review. Epidemiology. 2013; 24: 479-489.\n\n136Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015; 11(9): 1015-1022.\n\n137Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015; 11: 1007-1014.\n\n138Van den Brink AC, Brouwer-Broisma EM, Berendsen AAM van de Rest O. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets are associated with less cognitive decline and a lower risk of Alzheimer's disease: A review. Adv Nutr. 2019; 10: 1040-1065.\n\n139Ballarini T, Melo van Lent D, Brunner J, et al. Mediterranean diet, Alzheimer disease biomarkers and brain atrophy in old age. Neurology. 2021; 96(24): e2920-e2932.\n\n140Agarwal P, Leurgans SE, Agrawal S, et al. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023; 100(22): e2259-e2268.\n\n141Barnes LL, Dhana K, Liu X, et al. Trial of the MIND Diet for prevention of cognitive decline in older persons. N Engl J Med. 2023; 389(7): 602-611.\n\n142Grant WB, Steven M. Diet's role in modifying risk of Alzheimer's disease: History and present understanding. J Alzheimer's Dis. 2023; 96(4): 1353-1382.\n\n143Martinez-Gonzalez MA, Gea A, Ruiz-Canela M. The Mediterranean diet and cardiovascular health: A critical review. Circulation Res. 2019; 124: 779-798.\n\n144Sanches Machado d'Almeida K, Spillere SR, Zuchinali P, Souza GC. Mediterranean diet and other dietary patterns in primary prevention of heart failure and changes in cardiac function markers: A systematic review. Nutrients. 2018; 10: 58. doi:10.3390/nu10010058\n\n145Walker ME, O'Donnell AA, Himali JJ, et al. Associations of the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay diet with cardiac remodelling in the community: The Framingham Heart Study. Br J Nutr. 2021; 126(12): 1888-1896.\n\n146Butler M, Nelson VA, Davila H, et al. Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia. Ann Intern Med. 2018; 168: 52-62.\n\n147Kivimaki M, Luukkonen R, Batty GD, et al. Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals. Alzheimers Dement. 2018; 14: 601-609.\n\n148Gottesman RF, Schneider AL, Zhou Y, et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 2017; 17(14): 1443-1450.\n\n149Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: Review and meta-analysis. J Alzheimers Dis. 2017; 56(1): 215-228.\n\n150Marden JR, Tchetgen EJ, Kawachi I, Glymour MM. Contribution of Socioeconomic Status at 3 Life-Course Periods to Late-Life Memory Function and Decline: Early and Late Predictors of Dementia Risk. Am J Epidemiol. 2017; 186(7): 805-814.\n\n151Caunca MR, Odden MC, Glymour MM, et al. Association of Racial Residential Segregation Throughout Young Adulthood and Cognitive Performance in Middle-aged Participants in the CARDIA Study. JAMA Neurol. 2020; 77(8): 1000-1007.\n\n152Chen R, Williams DR, Nishimi K, Slopen N, Kubzansky LD, Weuve J. A life course approach to understanding stress exposures and cognitive function among middle-aged and older adults. Soc Sci Med. 2022; 314:115448.\n\n153George KM, Lutsey PL, Kucharska-Newton A, Palta P, Heiss G, Osypuk T, Folsom AR. Life-Course Individual and Neighborhood Socioeconomic Status and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study. Am J Epidemiol. 2020; 189(10): 1134-4112.\n\n154George KM, Gilsanz P, Peterson RL, et al. Impact of Cardiovascular Risk Factors in Adolescence, Young Adulthood, and Midlife on Late-Life Cognition: Study of Healthy Aging in African Americans. J Gerontol A Biol Sci Med Sci. 2021; 76(9): 1692-1698.\n\n155Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004; 52(2): 195-204.\n\n156Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol. 2002; 59(11): 1737-1746.\n\n157Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11): 1006-1012.\n\n158Sando SB, Melquist S, Cannon A, et al. Risk-reducing effect of education in Alzheimer's disease. Int J Geriatr Psychiatry. 2008; 23(11): 1156-1162.\n\n159Hendrie HC, Smith-Gamble V, Lane KA, Purnell C, Clark DO, Gao S. The Association of early life factors and declining incidence rates of dementia in an elderly population of African Americans. J Gerontol B Psychol Sci Soc Sci. 2018; 16(73, suppl 1): S82-S89.\n\n160Manly JJ, Jones RN, Langa KM, et al. Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022; 79(12): 1242-1249.\n\n161Rawlings AM, Sharrett AR, Mosley TH, Wong DF, Knopman DS, Gottesman RF. Cognitive reserve in midlife is not associated with amyloid-β deposition in late-life. J Alzheimers Dis. 2019: 517-521.\n\n162Wilson RS, Yu L, Lamar M, Schneider JA, Boyle PA, Bennett DA. Education and cognitive reserve in old age. Neurology. 2019; 92(10): e1041-e1050.\n\n163Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002; 8: 448-460.\n\n164Stern Y, Arenaza-Urquijo EM, Bartres-Faz D, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020; 16(9): 1305-1311.\n\n165Grzywacz JG, Segel-Karpas D, Lachman ME. Workplace exposures and cognitive function during adulthood: Evidence from National Survey of Midlife Development and the O*NET. J Occup Environ Med. 2016; 58(6): 535-541.\n\n166Pool LR, Weuve J, Wilson RS, Bültmann U, Evans DA, Mendes de Leon CF. Occupational cognitive requirements and late-life cognitive aging. Neurology. 2016; 86(15): 1386-1392.\n\n167Then FS, Luck T, Luppa M, et al. Association between mental demands at work and cognitive functioning in the general population: Results of the health study of the Leipzig Research Center for Civilization Diseases. J Occup Med Toxicol. 2014; 9: 23.\n\n168Fisher GG, Stachowski A, Infurna FJ, Faul JD, Grosch J, Tetrick LE. Mental work demands, retirement, and longitudinal trajectories of cognitive functioning. J Occup Health Psychol. 2014; 19(2): 231-242.\n\n169Coleman ME, Roessler MEH, Peng S, et al. Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia. Alzheimers Dement. 2023; 19(6): 2655-2665.\n\n170Soh Y, Eng CW, Mayeda ER, et al. Association of primary lifetime occupational cognitive complexity and cognitive decline in a diverse cohort: Results from the KHANDLE study. Alzheimers Dement. 2023; 19(9): 3926-3935.\n\n171McDowell I, Xi G, Lindsay J, Tierney M. Mapping the connections between education and dementia. J Clin Exp Neuropsychol. 2007; 29(2): 127-141.\n\n172Harris CD, Watson KB, Carlson SA, Fulton JE, Dorn JM, Elam-Evans L. Adult participation in aerobic and muscle-strengthening physical activities — United States, 2011. Morb Mortal Wkly Rep. 2013; 62(17): 326-330.\n\n173Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015; 314(10): 1021-1029.\n\n174Sims M, Diez Roux AV, Boykin S, et al. The socioeconomic gradient of diabetes prevalence, awareness, treatment, and control among African Americans in the Jackson Heart Study. Ann Epidemiol. 2011; 21(12): 892-898.\n\n175Lee TC, Glynn RJ, Peña JM, et al. Socioeconomic status and incident type 2 diabetes mellitus: Data from the Women's Health Study. PLoS One. 2011; 6(12):E27670.\n\n176Gillespie CD, Hurvitz KA. Prevalence of hypertension and controlled hypertension — United States, 2007–2010. MMWR. 2013; 62(3): 144-148.\n\n177 Centers for Disease Control and Prevention. Current Cigarette Smoking Among Adults in the United States. Accessed December 15, 2023. Available at: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm\n\n178Kweon H, Aydogan G, Dagher A, et al. Human brain anatomy reflects separable genetic and environmental components of socioeconomic status. Sci Adv. 2022; 8(20):eabm2923.\n\n179Weuve J, Bennett EE, Ranker L, et al. Exposure to air pollution in relation to risk of dementia and related outcomes: An updated systematic review of the epidemiologic literature. Environ Health Perspect. 2021; 129(9):96001.\n\n180Bernard SM, McGeehin MA. Prevalence of blood lead levels >or= 5 micro g/dL among US children 1 to 5 years of age and socioeconomic and demographic factors associated with blood of lead levels 5 to 10 micro g/dL, Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics. 2003; 112(6 Pt 1): 1308-1313.\n\n181Griffith M, Tajik M, Wing S. Patterns of agricultural pesticide use in relation to socioeconomic characteristics of the population in the rural U.S. South. Int J Health Serv. 2007; 37(2): 259-277.\n\n182Staff RT, Hogan MJ, Williams DS, Whalley LJ. Intellectual engagement and cognitive ability in later life (the “use it or lose it” conjecture): Longitudinal, prospective study. BMJ. 2018; 363:k4925.\n\n183Karp A, Paillard-Borg S, Wang H-X, Silverstein M, Winblad B, Fratiglioni L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord. 2005; 21(2): 65-73.\n\n184Di Marco LY, Marzo A, Muñoz-Ruiz M, et al. Modifiable lifestyle factors in dementia: A systematic review of longitudinal observational cohort studies. J Alzheimers Dis. 2014; 42(1): 119-135.\n\n185James BD, Wilson RS, Barnes LL, Bennett DA. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc. 2011; 17(6): 998-1005.\n\n186Yates LA, Ziser S, Spector A, Orrell M. Cognitive leisure activities and future risk of cognitive impairment and dementia: Systematic review and meta-analysis. Int Psychogeriatr. 2016; 9: 1-16.\n\n187Hall CB, Lipton RB, Sliwinski M, Katz MJ, Derby CA, Verghese J. Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology. 2009; 73: 356-361.\n\n188Sanjeev G, Weuve J, Jackson JW, et al. Late-life cognitive activity and dementia. Epidemiology. 2016; 27(5): 732-742.\n\n189Wang Z, Marseglia A, Shang Y, Dintica C, Patrone C, Xu W. Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study. Alzheimer's Dement. 2020; 16: 316-335.\n\n190Sommerlad A, Sabia S, Singh-Manoux A, Lewis G, Livingston G. Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study. PLoS Med. 2019; 16(8):e1002862.\n\n191 Centers for Disease Control and Prevention. Surveillance Report: Traumatic Brain Injury-Related Deaths by Age Group, Sex, and Mechanism of Injury. Accessed December 15, 2023. Available at: https://www.cdc.gov/traumaticbraininjury/pdf/TBI-surveillance-report-2018-2019-508.pdf\n\n192Fann JR, Ribe AR, Pedersen HS, et al. Long-term risk of dementia among people with traumatic brain injury in Denmark: A population-based observational cohort study. Lancet Psychiatry. 2018; 5(5): 424-431.\n\n193LoBue C, Munro C, Schaffert J, et al. Traumatic brain injury and risk of long-term brain changes, accumulation of pathological markers, and developing dementia: A review. J Alzheimers Dis. 2019; 70(3): 629-654.\n\n194Schneider ALC, Selvin E, Latour L, et al. Head injury and 25-year risk of dementia. Alzheimer's Dement. 2021; 17: 1432-1441.\n\n195 Centers for Disease Control and Prevention. TBI Data. Accessed December 15, 2023. Available at: https://www.cdc.gov/traumaticbraininjury/data/index.html\n\n196Plassman BL, Havlik RJ, Steffens DC, et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology. 2000; 55(8): 1158-1166.\n\n197Teasdale G, Jennett B. Assessment of coma and impaired consciousness: A practical scale. Lancet. 1974; 2(7872): 81-84.\n\n198 Centers for Disease Control and Prevention. Traumatic Brain Injury & Concussion. Potential Effects. Accessed December 15, 2023. Available at: https://www.cdc.gov/traumaticbraininjury/outcomes.html\n\n199Shively S, Scher AI, Perl DP, Diaz-Arrastia R. Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol. 2012; 69(10): 1245-1251.\n\n200LoBue C, Wadsworth H, Wilmoth K, Clem M, Hart J Jr, Womack KB. Traumatic brain injury history is associated with earlier age of onset of Alzheimer disease. Clin Neuropsychol. 2017; 31(1): 85-98.\n\n201Schaffert J, LoBue C, White CL, et al. Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology. 2018; 32(4): 410-416.\n\n202Stein TD, Montenigro PH, Alvarez VE, et al. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol. 2015; 130(1): 21-34.\n\n203Turk KW, Geada A, Alvarez VE, et al. A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. Alz Res Therapy. 2022; 14: 28. Accessed December 13, 2023. Available at: https://doi.org/10.1186/s13195-022-00976-y\n\n204Asken BM, Sullan MJ, DeKosky ST, Jaffee MS, Bauer RM. Research gaps and controversies in chronic traumatic encephalopathy: A review. JAMA Neurol. 2017; 74(10): 1255-1262.\n\n205Mez J, Daneshvar DH, Abdolmohammadi B, et al. Duration of American football play and chronic traumatic encephalopathy. Ann Neurol. 2020; 87(1): 116-131.\n\n206Nowinski CJ, Bureau SC, Buckland ME, et al. Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy. Front Neurol. 2022; 13:938163.\n\n207Shi L, Chen S, Ma M, et al. Sleep disturbances increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev. 2018; 40: 4-16.\n\n208Sabia S, Fayosse A, Dumurgier J, van Hees VT, Paquet C, Sommerlad A. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun. 2021; 12(1): 2289.\n\n209Winer JR, Keters KD, Kennedy G, et al. Association of short and long sleep duration with amyloid-β burden and cognition in aging. JAMA Neurol. 2021; 78(10): 1187-1196.\n\n210Makin S. Deep sleep gives your brain a deep clean: Slow-wave activity during dreamless slumber helps wash out neural detritus Scientific American Nov 1, 2019. Accessed December 15, 2023. Available at: https://www.scientificamerican.com/article/deep-sleep-gives-your-brain-a-deep-clean1/\n\n211Insel PS, Mohlenhoff BS, Neylan TC, Krystal AD, Mackin RS. Association of sleep and β-amyloid pathology among older cognitively unimpaired adults. JAMA Netw Open. 2021; 4(7):e2117573.\n\n212Andrade A, Bubu OM, Varga AW, Osorio RS. The relationship between obstructive sleep apnea and Alzheimer's disease. J Alzheimers Dis. 2018; 64(Suppl 1): S255-S270.\n\n213Bubu, OM, Andrade AA, Umasabor-Bubu U, et al. Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research. Sleep Med Rev. 2020; 50:101250.\n\n214Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer's disease: Role of amyloid, tau, and other factors. Neuropsychopharmacol. 2020; 45: 104-120.\n\n215Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat Rev Neurol. 2014; 10(2): 115-159.\n\n216Lucey BP. It's complicated: The relationship between sleep and Alzheimer's disease in humans. Neurobiol Dis. 2020: 144:105031.\n\n217Ju Y-ES, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013; 70(5): 587-593.\n\n218Lao XQ, Liu X, Deng HB, et al. Sleep quality, Sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J Clin Sleep Med. 2018; 14(1): 109-117.\n\n219 U.S. Environmental Protection Agency. 2019. Integrated science assessment (ISA) for particulate matter (final report, 2019). EPA/600/R-19/188. Washington, DC.\n\n220Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air Pollution and Dementia: A Systematic Review. J Alzheimers Dis. 2019; 70(s1): S145-S163.\n\n221Zhang B, Weuve J, Langa KM, et al. Comparison of particulate air pollution from different emission sources and incident dementia in the U.S. JAMA Intern Med. 2023. doi:10.1001/jamainternmed.2023.3300\n\n222Abolhasani E, Hachinski V, Ghazaleh N, Azarpazhooh MR, Mokhber N, Martin J. Air pollution and Incidence of dementia: A systematic review and meta-analysis. Neurology. 2022. doi:10.1212/WNL.0000000000201419\n\n223Sprung J, Knopman DS, Petersen RC, et al. Association of hospitalization with long-term cognitive trajectories in older adults. J Am Geriatr Soc. 2021; 69(3): 660-668.\n\n224James BD, Wilson RS, Capuano AW, et al. Cognitive decline after elective and nonelective hospitalizations in older adults. Neurology. 2019; 92(7): e690-e699.\n\n225Brown CH, Sharrett AR, Coresh J, et al. Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort. Neurology. 2015; 84: 1443-1453.\n\n226Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013; 369(14): 1306-1336.\n\n227Ehlenbach WJ, Hough CL, Crane PK, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010; 303(8): 763-770.\n\n228Mart MF, Pun BT, Pandharipande P, Jackson JC, Ely EW. ICU survivorship - The Relationship of delirium, sedation, dementia, and acquired weakness. Crit Care Med. 2021; 49(8): 1227-1240.\n\n229James BD, Wilson RS, Capuano AW, et al. Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019; 86(6): 844-852.\n\n230Fong TG, Inouye SK. The inter-relationship between delirium and dementia: The importance of delirium prevention. Nat Rev Neurol. 2022; 18(10): 579-596.\n\n231Kim JE, Tamres LK, Orbell SL, et al. “And does that necessarily mean absolutely Alzheimer's?” An Analysis of questions raised following amyloid PET results disclosure. Am J Geriat Psychiat. Published August 13, 2023. doi:10.1016/j.jagp.2023.08.005\n\n232Largent EA, Bradbury AR. Bringing Alzheimer disease testing and results disclosure Into the 21st Century Cures Act. JAMA Neurol. 2022; 79(3): 219-220.\n\n233Erickson CM, Clark LR, Ketchum FB, Chin NA, Gleason CE Largent EA. Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society. Alzheimers Dement: DADM. 2022. doi:10.1002/dad2.12339\n\n234Barnes LL. Alzheimer disease in African American individuals: increased incidence or not enough data? Nat Rev Neurol. 2022; 18(1): 56-62.\n\n235 Administration for Community Living. 2020 Profile of Older Americans: May 2021. Accessed December 15, 2023. Available at: https://acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2020ProfileOlderAmericans.Final_.pdf\n\n236Gilmore-Bykovskyi A, Croff R, Glover CM, et al. Traversing the aging research and health equity divide: Toward intersectional frameworks of research justice and participation. Gerontologist. 2022; 62(5): 711-720.\n\n237 U.S. Census Bureau. 2023 National Population Projections: Downloadable Files. Accessed December 15, 2023. Available at: https://www.census.gov/data/tables/2023/demo/popproj/2023-summary-tables.html\n\n238 Administration on Aging, Administration for Community Living, U.S. Department of Health and Human Services. A Profile of Older Americans: 2016. Accessed December 15, 2023. Available at: https://www.acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2016-Profile.pdf\n\n239Guerreiro R, Bras J. The age factor in Alzheimer's disease. Genome Med. 2015; 7: 106.\n\n240Hudomiet P, Hurd MD, Rohwedder S. Trends in inequalities in the prevalence of dementia in the United States. Proc Natl Acad Sci USA. 2022; 119(46):e2212205119.\n\n241Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical AD and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement. 2021; 17(12): 1966-1975.\n\n242Hendriks S, Peetoom K, Bakker C, et al. Global prevalence of young-onset dementia: A systematic review and meta-analysis. JAMA Neurol. 2021; 78(9): 1080-1090.\n\n243James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016; 139(11): 2983-2993.\n\n244Serrano-Pozo A, Qian J, Monsell SE, et al. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol. 2014; 75: 597-601.\n\n245Barnes LL, Leurgans S, Aggarwal NT, et al. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015; 85: 528-534.\n\n246Petersen RC, Aisen P, Boeve BF, et al. Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol. 2013; 74(2): 199-208.\n\n247Rabinovici GD, Gatsonis C, Apgar C, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019; 321(13): 1286-1294.\n\n248 U.S. Census Bureau. 2023 National Populaiton Prpojections Tables: Main Series. Accessed December 15, 2023. Available at: https://www.census.gov/data/tables/2023/demo/popproj/2023-summary-tables.html\n\n249Jack CR Jr, Therneau TM, Weigand SD, et al. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer's Association Research Framework. JAMA Neurol. 2019; 76(10): 1174-1783.\n\n250Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimers Dement. 2022. doi:10.1002/alz.12694\n\n251Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement. 2018; 14(2): 121-129.\n\n252Kotagal V, Langa KM, Plassman BL, et al. Factors associated with cognitive evaluations in the United States. Neurology. 2015; 84(1): 64-71.\n\n253Taylor DH, Jr., Ostbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: The case of dementia revisited. J Alzheimers Dis. 2009; 17(4): 807-815.\n\n254Gianattasio KZ, Prather C, Glymour MM, Ciarleglio A, Power MC. Racial disparities and temporal trends in dementia misdiagnosis risk in the United States. Alzheimer's & Dementia. 2019; 5: 891-898.\n\n255Lang L, Clifford A, Wei L, et al. Prevalence and determinants of undetected dementia in the community: A systematic literature review and a meta-analysis. BMJ Open. 2017; 7(2):e011146.\n\n256Lin PJ, Daly AT, Olchanski N, et al. Dementia diagnosis disparities by race and ethnicity. Med Care. 2021; 59(8): 679-686.\n\n257Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM. Underdiagnosis of dementia: An observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med. 2018; 33(7): 1131-1138.\n\n258Nguyen HQ, Borson S, Khang P, et al. Dementia diagnosis and utilization patterns in a racially diverse population within an integrated health care delivery system. Alzheimers Dement (N Y). 2022; 8(1):e12279.\n\n259Grodstein F, Chang C-H, Capuano AW, Power MC, Marquez DX, Barnes LL. Identification of Dementia in Recent Medicare Claims Data, Compared With Rigorous Clinical Assessments. J Gerontol A Biol Sci Med Sci. 2022; 77(6): 1272-1278.\n\n260Grodstein F, James BD, Chen Y, et al. Identification of dementia in Medicare claims compared to rigorous clinical assessments in African Americans. J Gerontol A Biol Sci Med Sci. 2023; 30:glad235. doi:10.1093/gerona/glad235\n\n261Chen Y, Tysinger B, Crimmins E, Zissimopoulos JM. Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data. Alzheimers Dement (N Y). 2019; 5: 197-207.\n\n262 Healthy People 2030. Accessed December 15, 2023. Available at: https://health.gov/healthypeople/objectives-and-data/browse-objectives/dementias/increase-proportion-older-adults-dementia-or-their-caregivers-who-know-they-have-it-dia-01\n\n263Barrett AM, Orange W, Keller M, Damgaard P, Swerdlow RH. Short-term effect of dementia disclosure: How patients and families describe the diagnosis. J Am Geriatr Soc. 2006; 54(12): 1968-1970.\n\n264Zaleta AK, Carpenter BD, Porensky EK, Xiong C, Morris JC. Agreement on diagnosis among patients, companions, and professionals after a dementia evaluation. Alzheimer Dis Assoc Disord. 2012; 26(3): 232-237.\n\n265Amjad H, Roth DL, Samus QM, Yasar S, Wolff JL. Potentially unsafe activities and living conditions of older adults with dementia. J Am Geriatr Soc. 2016; 64(6): 1223-1232.\n\n266 Alzheimer's Association. 2015 Alzheimer's Disease Facts and Figures. Special report: Disclosing a diagnosis of Alzheimer's disease. Accessed December 15, 2023. Available at: https://www.alzheimersanddementia.com/article/S1552-5260(15)00058-8/fulltext\n\n267 Alzheimer's Association. 2019 Alzheimer's Disease Facts and Figures. Special report: Alzheimer's detection in the primary care setting — connecting patients with physicians. Accessed December 15, 2023. Available at: https://www.alzheimersanddementia.com/article/S1552-5260(19)30031-7/fulltext\n\n268Qian Y, Chen X, Tang D, Kelley AS, Li J. Prevalence of memory-related diagnoses among U.S. older adults with early symptoms of cognitive impairment. J Gerontol A 76(10): 1846-1853.\n\n269Power MC, Willens V, Prather C, et al. Risks and benefits of clinical diagnosis around the time of dementia onset. Gerontol Geriatr Med. 2023; 9:23337214231213185.\n\n270Spargo D, Zur R, Lin PJ, Synnott P, Klein E, Hartry A. Estimating prevalence of early symptomatic Alzheimer's disease in the United States. Alzheimers Dement (Amst). 2023; 15(4):e12497.\n\n271Liu Y, Jun H, Becker A, Wallick C, Mattke S. Detection rates of mild cognitive impairment in primary care for the United States Medicare population. J Prev Alzheimers Dis. 2023. Accessed December 15, 2023. Available at: https://link.springer.com/article/10.14283/jpad.2023.131\n\n272Reisberg B, Gauthier S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr. 2008; 20(1): 1-16.\n\n273Jessen F, Wolfsgruber S, Wiese B, et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2014; 10(1): 76-83.\n\n274Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6): 844-852.\n\n275Buckley RF, Maruff P, Ames D, et al. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimers Dement. 2016; 12(7): 796-804.\n\n276Gifford KA, Liu D, Lu Z, et al. The source of cognitive complaints predicts diagnostic conversion differentially among nondemented older adults. Alzheimers Dement. 2014; 10(3): 319-327.\n\n277Kaup AR, Nettiksimmons J, LeBlanc ES, Yaffe K. Memory complaints and risk of cognitive impairment after nearly 2 decades among older women. Neurology. 2015; 85(21): 1852-1858.\n\n278Reisberg B, Shulman MB, Torossian C, Leng L, Zhu W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement. 2010; 6(1): 11-24.\n\n279Fernandez-Blazquez MA, Avila-Villanueva M, Maestu F, Medina M. Specific features of subjective cognitive decline predict faster conversion to mild cognitive impairment. J Alzheimers Dis. 2016; 52(1): 271-281.\n\n280Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020; 19(3): 271-278.\n\n281Wolfsgruber S, Kleineidam L, Wagner M, et al. Differential risk of incident Alzheimer's disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimers Dis. 2016; 54(3): 1135-1146.\n\n282 Unpublished data from the 2019-2020 Behavioral Risk Factor Surveillance System survey conducted in 46 states and the District of Columbia, analyzed and provided to the Alzheimer's Association by the Alzheimer's Disease Program, Centers for Disease Control and Prevention.\n\n283Dhana K, Beck T, Desai P, Wilson RS, Evans DA, Rajan KB. Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: A population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics. Alz Dement. 2023; 19(10): 4388-4395.\n\n284Rajan KB, Weuve J, Barnes LL, Wilson RS, Evans DA. Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study. Alzheimers Dement. 2019; 15(1): 1-7.\n\n285Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 2001; 15(4): 169-173.\n\n286Chene G, Beiser A, Au R, et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement. 2015; 11(3): 310-320.\n\n287 U.S. Census Bureau. 2014 National Population Projections: Downloadable Files. Accessed December 15, 2023. Available at: https://www.census.gov/data/datasets/2014/demo/popproj/2014-popproj.html\n\n288Seshadri S, Wolf PA, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology. 1997; 49(6): 1498-1504.\n\n289Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol. 2001; 153(2): 132-136.\n\n290Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology. 2000; 54(11): 2072-2077.\n\n291Zahodne LB, Schofield PW, Farrell MT, Stern Y, Manly JJ. Bilingualism does not alter cognitive decline or dementia risk among Spanish-speaking immigrants. Neuropsychology. 2014; 28(2): 238-246.\n\n292Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997; 48: 132-138.\n\n293Letenneur L, Gilleron V, Commenges D, Helmer C, Orgogozo JM, Dartigues JF. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry. 1999; 66: 177-183.\n\n294Matthews FE, Stephan BC, Robinson L, et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun. 2016; 7:11398.\n\n295Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS. Sex and gender in Alzheimer's disease — Does it matter? Alzheimers Dement. 2018; 14(9): 1101-1103.\n\n296Rocca WA. Time, Sex, gender, history, and dementia. Alzheimer Dis Assoc Disord. 2017; 31(1): 76-79.\n\n297Shaw C, Hayes-Larson E, Glymour MM, Dufouil C, Hohman TJ, Whitmer RA. Evaluation of selective survival and sex/gender differences in dementia incidence using a simulation model. JAMA Netw Open. 2021; 4(3):e211001.\n\n298Gilsanz P, Lee C, Corrada MM, Kawas CH, Quesenberry CP, Jr., Whitmer RA. Reproductive period and risk of dementia in a diverse cohort of health care members. Neurology. 2019; 92(17): e2005-e2014.\n\n299Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer's disease: Assessing sex and gender differences. Clin Epidemiol. 2014; 6: 37-48.\n\n300Mielke MM, Aggarwal NT, Vila-Castelar C, et al. Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective. Alzheimers Dement. 2022. doi:10.1002/alz.12662\n\n301Rocca WA, Mielke MM, Vemuri P, Miller VM. Sex and gender differences in the causes of dementia: A narrative review. Maturitas. 2014; 79(2): 196-201.\n\n302Langa KM, Larson EB, Crimmins EM, et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017; 177(1): 51-58.\n\n303Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 1999; 52(1): 78-84.\n\n304Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimaki M, Batty GD. Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK. Br J Psychiatry. 2013; 203(1): 10-17.\n\n305Mayeda RM, Mobley TM, Weiss RE, Murchland AR, Berkman LF, Sabbath EL. Association of work-family experience with mid- and late-life memory decline in US women. Neurology. 2020; e3072-33080.\n\n306Mielke MM, James BD. Women who participated in the paid labor force have lower rates of memory decline: Working to remember. Neurolgy. 2020; 95(23): 1027-1028.\n\n307 Population Reference Bureau. Women, Work, and the COVID Pandemic: Myths and Realities. Accessed December 15, 2023. Available at: https://www.prb.org/articles/blog-u-s-women-work-and-the-covid-pandemic-myths-and-realities\n\n308Zamarro G, Prados MJ. “Gender Differences in Couples' Division of Childcare, Work, and Mental Health During COVID-19.” Rev Econ Househ. 2021; 19(1): 11-40.\n\n309 Center for American Progress. Calculating the Hidden Cost of Interrupting a Career for Child Care. Accessed December 15, 2023. Available at: https://www.americanprogress.org/article/calculating-the-hidden-cost-of-interrupting-a-career-for-child-care/\n\n310Carter CL, Resnick EM, Mallampalli M, Kalbarczyk A. Sex and gender differences in Alzheimer's disease: Recommendations for future research. J Womens Health. 2012; 21(10): 1018-1023.\n\n311Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer's Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75(4): 563-573.\n\n312Ungar L, Altmann A, Greicius MD. Apolipoprotein E, gender, and Alzheimer's disease: An overlooked, but potent and promising interaction. Brain Imaging Behav. 2014; 8(2): 262-273.\n\n313Hohman TJ, Dumitrescu L, Barnes LL, et al. Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018; 75(8): 989-998.\n\n314Neu SC, Pa J, Kukull W, et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis. JAMA Neurol. 2017; 74(10): 1178-1189.\n\n315Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction. Neurology. 2000; 54(10): 1949-1954.\n\n316Kang JH, Grodstein F. Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging. 2012; 33(7): 1129-1137.\n\n317Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S. Diagnosis and assessment of Alzheimer's disease in diverse populations. Alzheimers Dement. 2008; 4(4): 305-309.\n\n318Manly JJ, Mayeux R. Ethnic differences in dementia and Alzheimer's disease. In: N Anderson, R Bulatao, B Cohen, eds. Critical perspectives on racial and ethnic differentials in health in late life. Washington, D.C.: National Academies Press; 2004: p. 95-141.\n\n319Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: The South Florida Program on Aging and Health. Ann Epidemiol. 2003; 13(6): 472-478.\n\n320Harwood DG, Ownby RL. Ethnicity and dementia. Curr Psych Report. 2000; 2(1): 40-45.\n\n321Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology. 1997; 49(1): 44-50.\n\n322Steenland K, Goldstein FC, Levey A, Wharton W. A meta-analysis of Alzheimer's disease incidence and prevalence comparing African-Americans and caucasians. J Alzheimers Dis. 2015; 50(1): 71-76.\n\n323Power MC, Bennett EE, Turner RW, et al. Trends in relative incidence and prevalence of dementia across non-Hispanic black and white individuals in the United States, 2000-2016. JAMA Neurology. 2021; 78(3): 275-284.\n\n324Potter GG, Plassman BL, Burke JR, et al. Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimers Dement. 2009; 5(6): 445-453.\n\n325Gurland BJ, Wilder DE, Lantigua R, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 1999; 14(6): 481-493.\n\n326Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 2003; 51: 169-177.\n\n327Samper-Ternent R, Kuo YF, Ray LA, Ottenbacher KJ, Markides KS, Al Snih S. Prevalence of health conditions and predictors of mortality in oldest old Mexican Americans and non-Hispanic whites. J Am Med Dir Assn. 2012; 13(3): 254-259.\n\n328Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Dement. 2017; 13(1): 72-83.\n\n329González HM, Tarraf W, Schneiderman N, et al. Prevalence and correlates of mild cognitive impairment among diverse Hispanics/Latinos: Study of Latinos-Investigation of Neurocognitive Aging results. Alzheimers Dement. 2019; 15(12): 1507-1515.\n\n330Yaffe K, Falvey C, Harris TB, et al. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: Prospective study. BMJ. 2013; 347:f7051.\n\n331Kornblith E, Bahorik A; Boscardin WJ; Xia F, Barnes DE, Yaffe K. Association of Race and Ethnicity With Incidence of Dementia Among Older Adults. JAMA. 2022; 327(15): 1488-1495.\n\n332Chin AL, Negash S, Hamilton R. Diversity and disparity in dementia: The impact of ethnoracial differences in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011; 25(3): 187-195.\n\n333Froehlich TE, Bogardus Jr. ST, Inouye SK. Dementia and race: Are there differences between African Americans and Caucasians? J Am Geriatr Soc. 2001; 49(4): 477-484.\n\n334Glymour MM, Manly JJ. Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychol Rev. 2008; 18(3): 223-254.\n\n335Bailey ZD, Feldman JM, Bassett MT. How Structural Racism Works - Racist Policies as a Root Cause of U.S. Racial Health Inequities. N Engl J Med. 2021; 384(8): 768-773.\n\n336Bailey ZD, Krieger N, Agenor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: Evidence and interventions. Lancet. 2017; 389(10077): 1453-1463.\n\n337Caunca MR, Odden MC, et al. Association of racial residential segregation throughout young adulthood and cognitive performance in middle-aged participants in the CARDIA study. JAMA Neurology. 2020; 77(8): 1000-1007.\n\n338Lamar M, Lerner AJ, James BD, et al. Relationship of early-life residence and educational experience to level and change in cognitive functioning: Results of the Minority Aging Research Study. J Gerontol B Psychol Sci Soc Sci. 2020; 75(7): e81-e92.\n\n339Peterson RL, George KM, Barnes LL, et al. Timing of School Desegregation and Late-Life Cognition in the Study of Healthy Aging in African Americans (STAR). JAMA Netw Open. 2021; 4(10):e2129052.\n\n340Bancks MP, Byrd GS, Caban-Holt A, et al. Self-reported experiences of discrimination and incident dementia. Alzheimers Dement. 2023; 19(7): 3119-3128.\n\n341Lines LM, Sherif NA, Wiener JM. Racial and ethnic disparities among individuals with Alzheimer's disease in the United States: A literature review. Research Triangle Park, NC: RTI Press; 2014.\n\n342Zhang Z, Hayward MD, Yu YL. Life course pathways to racial disparities in cognitive impairment among older Americans. J Health Soc Behav. 2016; 57(2): 184-199.\n\n343Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: The Aging, Demographics, and Memory Study. Neuroepidemiology. 2007; 29(1-2): 125-132.\n\n344Clark PC, Kutner NG, Goldstein FC, et al. Impediments to timely diagnosis of Alzheimer's disease in African Americans. J Am Geriatr Soc. 2005; 53(11): 2012-2017.\n\n345Fitten LJ, Ortiz F, Ponton M. Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics. J Am Geriatr Soc. 2001; 49(10): 1301-1308.\n\n346Matthews KA, Xu W, Gaglioti AH, et al. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥ 65 years. Alzheimers Dement. 2019; 15(1): 17-24.\n\n347Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016; 12(3): 216-224.\n\n348Mayeda ER, Glymour MM, Quesenberry CP, Jr., Whitmer RA. Heterogeneity in 14-year dementia incidence between Asian American subgroups. Alzheimer Dis Assoc Disord. 2017; 31(3): 181-186.\n\n349Ajrouch KJ, Zahodne LB, Antonucci TC. Arab American Cognitive Aging: Opportunities for Advancing Research on Alzheimer's Disease Disparities. Innov Aging. 2017; 1(3):igx034.\n\n350Flatt JD, Cicero EC, Lambrou NH, Wharton W, Anderson JG, Bouldin ED, McGuire LC, Taylor CA. Subjective cognitive decline higher among sexual and gender minorities in the United States, 2015-2018. Alzheimers dement. 2021; 7(1):e12197.\n\n351Liu H, Hsieh N, Zhang Z, Zhang Y, Langa KM. Same-sex couples and cognitive impairment: Evidence from the health and retirement study. J Gerontol B. 2021; 76(7): 1388-1399.\n\n352Hsieh N, Liu H, Lai WH. Elevated risk of cognitive impairment among older sexual minorities: Do health conditions, health behaviors, and social connections matter? Gerontologist. 2021; 61(3): 352-362.\n\n353Perales-Puchalt J, Gauthreaux K, Flatt J, Teylan MA, Resendez J, Kukull WA, Chan KCG, Burns J, Vidoni ED. Risk of dementia and mild cognitive impairment among older adults in same-sex relationships. Int J Geriatr Psychiatry. 2019; 34(6): 828-835.\n\n354Dragon CN, Guerino P, Ewald E, Laffan AM. Transgender Medicare beneficiaries and chronic conditions: exploring fee-for-service claims data. LGBT health. 2017; 4(6): 404-411.\n\n355Guo Y, Li Q, Yang X, Jaffee MS, Wu Y, Wang F, Bian J. Prevalence of Alzheimer's and Related Dementia Diseases and Risk Factors Among Transgender Adults, Florida, 20122020. Am J Public Health. 2022; 112(5): 754-757.\n\n356Romanelli RJ, Rosenblatt AS, Marcum ZA, Flatt JD. Cognitive Impairment in Sexual and Gender Minority Groups: A Scoping Review of the Literature. LGBT Health. 2023. doi:10.1089/lgbt.2023.0095\n\n357Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003; 129(5): 674-697.\n\n358Flatt JD, Johnson JK, Karpiak SE, Seidel L, Larson B, Brennan-Ing M. Correlates of Subjective Cognitive Decline in Lesbian, Gay, Bisexual, and Transgender Older Adults. J Alzheimers Dis. 2018; 64(1): 91-102.\n\n359Brennan-Ing M, Seidel L, Larson B, Karpiak SE. Social care networks and older LGBT adults: challenges for the future. J Homosex. 2014; 61(1): 21-52.\n\n360Cohen RA, Seider TR, Navia B: HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther. 2015; 7: 37.\n\n361Cicero EC, Lett E, Flatt JD, Benson GP, Epps F. Transgender Adults From Minoritized Ethnoracial Groups in the U.S. Report Greater Subjective Cognitive Decline. J Gerontol B Psychol Sci Soc Sci. 2023; 78(6): 1051-1059.\n\n362 Hill Collins, Patricia. Intersectionality as Critical Social Theory. Duke University Press; 2019.\n\n363Correro AN, Nielson KA. A review of minority stress as a risk factor for cognitive decline in lesbian, gay, bisexual, and transgender (LGBT) elders. J Gay Lesbian Ment Health. 2020; 24(1): 2-19.\n\n364Flatt JD, Cicero EC, Kittle KR, Brennan-Ing M. Recommendations for advancing research with sexual and gender minority older adults. J Gerontol B. 2022; 77(1): 1-9.\n\n365Wolters FJ, Chibnik LB, Waziry R, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States. The Alzheimer Cohorts Consortium. Neurology. 2020; 95(5): e519-e531.\n\n366Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 2011; 7(1): 80-93.\n\n367Wu YT, Beiser AS, Breteler MMB, et al. The changing prevalence and incidence of dementia over time: Current evidence. Nat Rev Neurol. 2017; 13(6): 327-339.\n\n368Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012; 78(19): 1456-1463.\n\n369Qiu C, von Strauss E, Backman L, Winblad B, Fratiglioni L. Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology. 2013; 80(20): 1888-1894.\n\n370Satizabal CL, Beiser AS, Chouraki V, Chene G, Dufouil C, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med. 2016; 374: 523-532.\n\n371Cerasuolo JO, Cipriano LE, Sposato LA, et al. Population-based stroke and dementia incidence trends: Age and sex variations. Alzheimers Dement. 2017; 13(10): 1081-1088.\n\n372Derby CA, Katz MJ, Lipton RB, Hall CB. Trends in dementia incidence in a birth cohort analysis of the Einstein Aging Study. JAMA Neurol. 2017; 74(11): 1345-1351.\n\n373Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, et al. Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: Modelling study. BMJ. 2017; 358:j2856.\n\n374Sullivan KJ, Dodge HH, Hughes TF, et al. Declining incident dementia rates across four population-based birth cohorts. J Gerontol A Biol Sci Med Sci. 2019; 74(9): 1439-1445.\n\n375Matthews FE, Arthur A, Barnes LE, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet. 2013; 382(9902): 1405-1412.\n\n376Wiberg P, Waern M, Billstedt E, Östling S, Skoog I. Secular trends in the prevalence of dementia and depression in Swedish septuagenarians 1976–2006. Psychol Med. 2013; 43: 2627-2634.\n\n377Wimo A, Sjölund BM, Sköldunger A, et al. Cohort effects in the prevalence and survival of people with dementia in a rural area in Northern Sweden. J Alzheimers Dis. 2016; 50: 387-396.\n\n378Hall KS, Gao S, Baiyewu O, et al. Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2000. Alzheimers Dement. 2009; 5(3): 227-233.\n\n379Farina MP, Zhang YS, Kim JK, Hayward MD, Crimmins EM. Trends in dementia prevalence, incidence, and mortality in the United States (2000-2016). J Aging Health. 2022; 34(1): 100-108.\n\n380van den Kommer TN, Deeg DJH, van der Flier WM, Comijs HC. Time trend in persistent cognitive decline: Results from the longitudinal aging study Amsterdam. J Gerontol B Psychol Sci Soc Sci. 2018; 73(Suppl 1) S57-S64.\n\n381Sekita A, Ninomiya T, Tanizaki Y, et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: The Hisayama Study. Acta Psychiatr Scand. 2010; 122(4): 319-325.\n\n382Gao S, Burney HN, Callahan CM, Purnell CE, Hendrie HC. Incidence of Dementia and Alzheimer Disease Over Time: A Meta-Analysis. J Am Geriatr Soc. 2019; 67(7): 1361-1369.\n\n383Crimmins EM, Saito Y, Kim JK, Zhang Y, Sasson I, Hayward MD. Educational differences in the prevalence of dementia and life expectancy with dementia in the United States: Changes from 2000 to 2010. J Gerontol B Psychol Sci Soc Sci. 2018; 73(Suppl 1): S20-S28.\n\n384Choi H, Schoeni RF, Martin LG, Langa K M. Trends in the prevalence and disparity in cognitive limitations of Americans 55-69 years old. J Gerontol B Psychol Sci Soc Sci. 2018; 73 (Suppl 1): S29-S37.\n\n385Zheng H. A New Look at Cohort Trend and Underlying Mechanisms in Cognitive Functioning. J Gerontol B Psychol Sci Soc Sci. 2021; 76(8): 1652-1663.\n\n386Freedman VA, Kasper JD, Spillman BC, Plassman BL. Short-term changes in the prevalence of probable dementia: An analysis of the 2011–2015 National Health and Aging Trends Study. J Gerontol B Psychol Sci Soc Sci. 2018; 73(Suppl 1) S48-S56.\n\n387Langa KM. Is the risk of Alzheimer's disease and dementia declining? Alzheimers Res Ther. 2015; 7(1): 34.\n\n388Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. N Engl J Med. 2013; 369(24): 2275-2277.\n\n389Sheffield KM, Peek MK. Changes in the prevalence of cognitive impairment among older Americans, 1993-2004: Overall trends and differences by race/ethnicity. Am J Epidemiol. 2011; 174(3): 274-283.\n\n390Weuve J, Rajan KB, Barnes LL, Wilson RS, Evans DA. Secular trends in cognitive performance in older black and white U.S. adults, 1993-2012: Findings from the Chicago Health and Aging Project. J Gerontol B Psychol Sci Soc Sci. 2018; 73 (Suppl 1): S73-S81.\n\n391Prince MJ, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends; 2015.\n\n392de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimers Dement. 2021; 17(6): 1056-1065.\n\n393Arias E, Tejada-Vera B, Kochanek KD, Ahmad FB. Provisional Life Expectancy Estimates for 2021. National Vital Statistics System, Report No. 23, 2022. Accessed December 15, 2023. Available at: https://www.cdc.gov/nchs/data/vsrr/vsrr023.pdf\n\n394 The World Bank. Fertility, total (births per woman)—US. Accessed December 15, 2023. Available at: https://data.worldbank.org/indicator/SP.DYN.TFRT.IN?locations=US\n\n395U .S. Census Bureau. 2017 National Population Projections Tables. Accessed December 15, 2023. Available at: https://www.census.gov/data/tables/2017/demo/popproj/2017-summary-tables.html\n\n396 Administration for Community Living. 2019 Profile of Older Americans. May 2020 Accessed December 15, 2023. Available at: https://acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2019ProfileOlderAmericans508.pdf\n\n397Bauman K. Shift Toward Greater Educational Attainment for Women Began 20 Years Ago. U.S. Census Bureau. Accessed December 15, 2023. Available at: https://www.census.gov/newsroom/blogs/random-samplings/2016/03/shift-toward-greater-educational-attainment-for-women-began-20-years-ago.html\n\n398 Population Reference Bureau. Why is the U.S. Birth Rate Declining? 2021. Accessed December 15, 2023. Available at: https://www.prb.org/resources/why-is-the-u-s-birth-rate-declining/\n\n399Horowitz JM, Igielnik R, Kochhar R. Trends in income and wealth inequality. Pew Research Center. Accessed October 28, 2023. Available at: https://www.pewresearch.org/social-trends/2020/01/09/trends-in-income-and-wealth-inequality/\n\n400Tom SE, Phadke M, Hubbard RA, Crane PK, Stern Y, Larson EB. Association of Demographic and Early-Life Socioeconomic Factors by Birth Cohort with Dementia Incidence Among US Adults Born Between 1893 and 1949. JAMA Netw Open. 2020; 3(7):e2011094.\n\n401Skoog I. Dementia incidence: The times, they are a-changing. Nature Rev Neurol. 2016; 12: 316-368. Accessed December 15, 2023. Available at: https://www.nature.com/articles/nrneurol.2016.55\n\n402 Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, Mortality 2018-2021 on CDC WONDER Online Database, released in 2021. Data are from the Multiple Cause of Death Files, 2018-2021, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed December 13, 2023. Accessed December 15, 2023. Available at: http://wonder.cdc.gov/ucd-icd10-expanded.html\n\n403 U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. CDC WONDER online database: About Provisional Mortality Statistics, 2018 through Last Month. https://wonder.cdc.gov/mcd-icd10-provisional.html\n\n404Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E. The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. JAMA. 2018; 319(14): 1444-1472.\n\n405 World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision. 2nd edition. WHO Press: Geneva, Switzerland; 2004.\n\n406Burns A, Jacoby R, Luthert P, Levy R. Cause of death in Alzheimer's disease. Age Ageing. 1990; 19(5): 341-344.\n\n407Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol. 2009; 16(4): 488-492.\n\n408Ives DG, Samuel P, Psaty BM, Kuller LH. Agreement between nosologist and Cardiovascular Health Study review of deaths: Implications of coding differences. J Am Geriatr Soc. 2009; 57(1): 133-139.\n\n409Romero JP, Benito-Leon J, Louis ED, Bermejo-Pareja F. Under reporting of dementia deaths on death certificates: A systematic review of population-based cohort studies. J Alzheimers Dis. 2014; 41(1): 213-221.\n\n410Ganguli M, Rodriguez EG. Reporting of dementia on death certificates: A community study. J Am Geriatr Soc. 1999; 47(7): 842-849.\n\n411Stokes AC, Weiss J, Lundberg DJ, et al. Estimates of the association of dementia with US mortality levels using linked survey and mortality records. JAMA Neurol. 2020; 77(12): 1543-1550.\n\n412 Unpublished tabulations based on data from the 100% National Sample Medicare Fee-for-Service Beneficiaries for 2019. Prepared under contract by Health Care Cost Institute, November 2021.\n\n413Weuve J, Hebert LE, Scherr PA, Evans DA. Deaths in the United States among persons with Alzheimer's disease (2010-2050). Alzheimers Dement. 2014; 10(2): E40-E46.\n\n414Arrighi HM, Neumann PJ, Lieberburg IM, Townsend RJ. Lethality of Alzheimer disease and its impact on nursing home placement. Alzheimer Dis Assoc Disord. 2010; 24(1): 90-95.\n\n415 Centers for Disease Control and Prevention. National Center for Health Statistics. Excess Deaths Associated with COVID-19. Accessed December 15, 2023. Available at: https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm\n\n416Gilstrap L, Zhou W, Alsan M, Nanda A, Skinner JS. Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic. JAMA Neurol. 2022; 79(4): 342-348.\n\n417Chen R, Charpignon M, Raquib RV, et al. Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US. JAMA Neurol. 2023; 80(9): 919-928.\n\n418Tejada-Vera B. Mortality from Alzheimer's disease in the United States: Data for 2000 and 2010. National Center for Health Statistics Data Brief, No. 116. National Center for Health Statistics, Hyattsville, MD; 2013.\n\n419Taylor C, Greenlund S, McGuire L, Lu H, Croft J. Deaths from Alzheimer's Disease — United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2017; 66: 521-526.\n\n420Mitchell SL, Teno JM, Miller SC, Mor V. A national study of the location of death for older persons with dementia. J Am Geriatr Soc. 2005; 53(2): 299-305.\n\n421 U.S. Burden of Disease Collaborators, Mokdad AH, Ballestros K, et al. The state of U.S. health, 1990-2016: Burden of diseases, injuries, and risk factors among U.S. states. JAMA. 2018; 319(14): 1444-1472.\n\n422Barker C, Green A. Opening the debate on DALYs (disability-adjusted life years). Health Policy Plan. 1996; 11(2): 179-183.\n\n423Gaugler JE, Kane RL, Kane RA. Family care for older adults with disabilities: Toward more targeted and interpretable research. Int J Aging Hum Dev. 2002; 54(3): 205-231.\n\n424Schulz R, Quittner AL. Caregiving through the life-span: Overview and future directions. Health Psychol. 1998; 17: 107-111.\n\n425Friedman EM, Shih RA, Langa KM, Hurd MD. U.S. prevalence and predictors of informal caregiving for dementia. Health Aff. 2015; 34(10): 1637-1641.\n\n426Spillman B, Wolff J, Freedman VA, Kasper JD. Informal Caregiving for Older Americans: An Analysis of the 2011 National Health and Aging Trends Study. Accessed December 15, 2023. Available at: https://aspe.hhs.gov/pdf-report/informal-caregiving-older-americans-analysis-2011-national-health-and-aging-trends-study\n\n427 Walmart: 2023 Annual Report. Accessed December 15, 2023. Available at: https://s201.q4cdn.com/262069030/files/doc_financials/2023/ar/Walmart-10K-Reports-Optimized.pdf\n\n428 McDonald's Corporation Report 2021. Accessed December 15, 2023. Available at: https://corporate.mcdonalds.com/content/dam/sites/corp/nfl/pdf/MCD%202021%20Annual%20Report.pdf\n\n429Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: Implications for policy. J Am Geriatr Soc. 2017; 65(10): 2169-2175.\n\n430 Official Data Foundation. CPI inflation calculator. Accessed December 15, 2023. Available at: http://www.in2013dollars.com/2017-dollars-in-2018?amount=139765\n\n431Deb A, Thornton JD, Sambamoorthi U, Innes K. Direct and indirect cost of managing Alzheimer's disease and related dementias in the United States. Expert Rev Pharmacoecon Outcomes Res. 2017; 17(2): 189-202.\n\n432Greenwood N, Smith R. Motivations for being informal carers of people living with dementia: A systematic review of qualitative literature. BMC Geriatr. 2019; 19(1): 169.\n\n433Kasper JD, Freedman VA, Spillman BC, Wolff JL. The disproportionate impact of dementia on family and unpaid caregiving to older adults. Health Aff. 2015; 34(10): 1642-1649.\n\n434Ornstein KA, Wolff JL, Bollens-Lund E, Rahman OK, Kelley AS. Spousal caregivers are caregiving alone in the last years of life. Health Aff (Millwood). 2019; 38(6): 964-972.\n\n435 Alzheimer's Association. Issues Brief: LGBT and Dementia. Accessed December 15, 2023. Available at https://www.alz.org/media/Documents/lgbt-dementia-issues-brief.pdf\n\n436Fredriksen-Goldsen KI, Jen S, Bryan AEB, Goldsen J. Cognitive impairment, Alzheimer's disease, and other dementias in the lives of lesbian, gay, bisexual and transgender (LGBT) older adults and their caregivers: Needs and competencies. J Appl Gerontol. 2018; 37(5): 545-569.\n\n437Candrian C, Burke ES, Kline D, Torke AM. Experiences of caregiving with Alzheimer's disease in the LGBT community. BMC Geriatr. 2023; 23(1): 293.\n\n438Anderson JG, Flatt JD, Jabson Tree JM, Gross AL, Rose KM. Characteristics of Sexual and Gender Minority Caregivers of People With Dementia. J Aging Health. 2021; 33(10): 838-851.\n\n439Kasper JD, Freedman VA, Spillman BC. Disability and Care Needs of Older Americans by Dementia Status: An Analysis of the 2011 National Health and Aging Trends Study. U.S. Department of Health and Human Services; 2014. Accessed December 15, 2023. Available at: http://aspe.hhs.gov/report/disability-and-care-needs-older-americans-dementia-status-analysis-2011-national-health-and-aging-trends-study\n\n440Rabarison KM, Bouldin ED, Bish CL, McGuire LC, Taylor CA, Greenlund KJ. The economic value of informal caregiving for persons with dementia: Results from 38 states, the District of Columbia, and Puerto Rico, 2015 and 2016 BRFSS. Am J Public Health. 2018; 108(10): 1370-1377.\n\n441 National Alliance for Caregiving in Partnership with the Alzheimer's Association. Dementia Caregiving in the U.S. Bethesda, MD. Accessed December 15, 2023. Available at: https://www.caregiving.org/wp-content/uploads/2020/05/Dementia-Caregiving-in-the-US_February-2017.pdf\n\n442 Unpublished data from the 2015, 2016 and 2017 Behavioral Risk Factor Surveillance System survey, analyzed by and provided to the Alzheimer's Association by the Alzheimer's Disease and Healthy Aging Program (AD+HP), Centers for Disease Control and Prevention (CDC).\n\n443Fisher GG, Franks MM, Plassman BL, et al. Caring for individuals with dementia and cognitive impairment, not dementia: Findings from The Aging, Demographics, and Memory Study. J Am Geriatr Soc. 2011; 59(3): 488-494.\n\n444Riffin C, Van Ness PH, Wolff JL, Fried T. Family and other unpaid caregivers and older adults with and without dementia and disability. J Am Geriatr Soc. 2017; 65(8): 1821-1828.\n\n445 National Poll on Healthy Aging. Dementia Caregivers: Juggling, Delaying and Looking Forward. Accessed December 15, 2023. Available at: http://www.healthyagingpoll.org/sites/default/files/2017-10/NPHA_Caregivers-Report-PROOF_101817_v2.pdf\n\n446 Caregiving in the U.S.: 2020 Report. Accessed December 15, 2023. Available at: https://www.aarp.org/content/dam/aarp/ppi/2020/05/full-report-caregiving-in-the-united-states.doi.10.26419-2Fppi.00103.001.pdf\n\n447Ohno S, Chen Y, Sakamaki H, Matsumaru N, Yoshino M, Tsukamoto K. Burden of caring for Alzheimer's disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional survey. J Med Econ. 2021; 24(1): 266-278.\n\n448 National Alliance for Caregiving and AARP. Caregiving in the U.S.: Unpublished data analyzed under contract for the Alzheimer's Association; 2009.\n\n449 Alzheimer's Association. 2014 Alzheimer's Disease Facts and Figures. Special Report: Women and Alzheimer's Disease. Accessed December 15, 2023. Available at: https://www.alzheimersanddementia.com/article/S1552-5260(14)00062-4/fulltext\n\n450Xiong C, Biscardi M, Astell A, et al. Sex and gender differences in caregiving burden experienced by family caregivers of persons with dementia: A systematic review. PLoS One. 2020; 15(4):e0231848.\n\n451Pinquart M, Sörensen. Gender differences in caregiver stressors, social resources, and health: An updated meta-analysis. J Gerontol B Psychol Sci Soc Sci. 2006; 61(1): P33-P45.\n\n452Ma M, Dorstyn D, Ward L, Prentice S. Alzheimer's disease and caregiving: A meta-analytic review comparing the mental health of primary carers to controls. Aging Ment Health. 2017; 5: 1-11.\n\n453Roberts HL, Bollens-Lund E, Ornstein KA, Kelley AS. Caring for aging parents in the last years of life. J Am Geriatr Soc. 2023; 71(9): 2871-2877.\n\n454Fabius CD, Wolff JL, Kasper JD. Race differences in characteristics and experiences of black and white caregivers of older Americans. Gerontologist. 2020; 60(7): 1244-1253.\n\n455Moon HE, Rote SM, Sears J, Schepens Niemiec SL. Racial Differences in the Dementia Caregiving Experience during the COVID-19 Pandemic: Findings from the National Health and Aging Trends Study (NHATS). J Gerontol B Psychol Sci Soc Sci. 2022;gbac098.\n\n456Liu R, Chi I, Wu S. Caregiving Burden Among Caregivers of People With Dementia Through the Lens of Intersectionality. Gerontologist. 2022; 62(5): 650-661.\n\n457Parker LJ, Fabius CD. Racial differences in respite use among black and white caregivers for people living with dementia. J Aging Health. 2020; 32(10): 1667-1675.\n\n458Ejem D, Atkins GC, Perkins M, Morhardt DJ, Williams IC, Cothran FA. Stressors and Acceptability of Services Among Black Caregivers of Persons With Memory Problems. J Gerontol Nurs. 2022; 48(6): 13-18.\n\n459Rote SM, Angel JL, Moon H, Markides K. Caregiving across diverse populations: New evidence from the National Study of Caregiving and Hispanic EPESE. Innov Aging. 2019; 3(2):igz033.\n\n460Pinquart M, Sörensen S. Ethnic differences in stressors, resources, and psychological outcomes of family caregiving: A meta-analysis. Gerontologist. 2005; 45(1): 90-106.\n\n461Dilworth-Anderson P, Moon H, Aranda MP. Dementia caregiving research: Expanding and reframing the lens of diversity, inclusivity, and intersectionality. Gerontologist. 2020; 60(5): 797-805.\n\n462Chen C, Thunell J, Zissimopoulos J. Changes in physical and mental health of Black, Hispanic, and White caregivers and non-caregivers associated with onset of spousal dementia. Alzheimers Dement (N Y). 2020; 6(1):e12082.\n\n463Cothran FA, Chang E, Beckett L, Bidwell JT, Price CA, Gallagher-Thompson D. A Landscape of Subjective and Objective Stress in African-American Dementia Family Caregivers. West J Nurs Res. 2022; 44(3): 239-249.\n\n464Liu C, Badana ANS, Burgdorf J, Fabius CD, Roth DL, Haley WE. Systematic review and meta-analysis of racial and ethnic differences in dementia caregivers' well-being. Gerontologist. 2021; 61(5): e228-e243.\n\n465Baik D, Centi S, McNair B. Assessing racial and ethnic differences in cardiovascular disease in U.S. family caregivers of persons with dementia: Analysis of data from the 2015-2020 Behavioral Risk Factor Surveillance System. Res Gerontol Nurs. 2023; 16(5): 241-249.\n\n466Brewster GS, Bonds K, McLennon S, Moss KO, Epps F, Lopez RP. Missing the Mark: The Complexity of African American Dementia Family Caregiving. J Fam Nurs. 2020; 26(4): 294-301.\n\n467Lewis JP, Manson SM, Jernigan VB, Noonan C. \"Making Sense of a Disease That Makes No Sense\": Understanding Alzheimer's Disease and Related Disorders Among Caregivers and Providers Within Alaska Native Communities. Gerontologist. 2021; 61(3): 363-373.\n\n468Parker LJ, Fabius C. Who's Helping Whom? Examination of care arrangements for racially and ethnically diverse people living with dementia in the community. J Appl Gerontol. 2022; 41(12): 2589-2593.\n\n469Idorenyin Imoh U, Charity T. Cultural and Social Factors in Care Delivery Among African American Caregivers of Persons With Dementia: A Scoping Review. Gerontol Geriatr Med. 2023; 9:23337214231152002.\n\n470Ta Park VM, Ly Q, von Oppenfeld J, et al. A scoping review of dementia caregiving for Korean Americans and recommendations for future research. Clin Gerontol. 2023; 46(2): 223-239.\n\n471Moraes Balbim G, Magallanes M, Marques IG, et al. Sources of caregiving burden in middle-aged and older Latino caregivers. J Geriatr Psychiatry Neurol. 2020; 33(4): 185-194.\n\n472Jaldin MA, Balbim GM, Colin SJ, et al. The influence of Latino cultural values on the perceived caregiver role of family members with Alzheimer's disease and related dementias. Ethn Health. 2023; 28(4): 619-633.\n\n473Martinez IL, Gonzalez EA, Quintero C, Vania MJ. The Experience of Alzheimer's Disease Family Caregivers in a Latino Community: Expectations and incongruences in support services. J Gerontol B Psychol Sci Soc Sci. 2022; 77(6): 1083-1893.\n\n474Sloan DH, Johnston D, Fabius C, Pyatt T, Antonsdottir I, Reuland M. Transcending inequities in dementia care in Black communities: Lessons from the maximizing independence at home care coordination program. Dementia (London). 2022; 21(5): 1653-1668.\n\n475Rote SM, Moon HE, Kacmar AM, Moore S. Exploring Coping Strategies and Barriers in Dementia Care: A Mixed-Methods Study of African American Family Caregivers in Kentucky. J Appl Gerontol. 2022; 41(8): 1851-1859.\n\n476Alexander K, Oliver S, Bennett SG, Henry J, Hepburn K, Clevenger C. \"Falling between the cracks\": Experiences of Black dementia caregivers navigating U.S. health systems. J Am Geriatr Soc. 2022; 70(2): 592-600.\n\n477Bonner GJ, Freels S, Ferrans C, et al. Advance Care Planning for African American Caregivers of Relatives With Dementias: Cluster Randomized Controlled Trial. Am J Hosp Palliat Care. 2021; 38(6): 547-556.\n\n478Meyer OL, Sun M, Do T, et al. Community-Engaged Research with Vietnamese Americans to Pilot-Test a Dementia Caregiver Intervention. J Cross Cult Gerontol. 2020; 35(4): 479-492.\n\n479Fields NL, Xu L, Richardson VE, Parekh R, Ivey D, Calhoun M. Utilizing the Senior Companion Program as a platform for a culturally informed caregiver intervention: Results from a mixed methods pilot study. Dementia (London). 2021; 20(1): 161-187.\n\n480Guest MA, Smith MP. In Our Community, Dementia Speaks: Pilot of a person-centered training targeting African-American caregivers of persons-living with dementia (innovative practice). Dementia (London). 2021; 20(1): 391-397.\n\n481Withers M, Cortez-Sanchez K, Herrera J, Ringman JM, Segal-Gidan F. \"My backpack is so heavy\": Experiences of Latino caregivers of family with early-onset Alzheimer's. J Am Geriatr Soc. 2021; 69(6): 1539-1547.\n\n482Epps F, Heidbreder V, Alexander K, Tomlinson A, Freeman V, Williams N. A dementia-friendly church: How can the African American church support families affected by dementia? Dementia (London). 2021; 20(2): 556-569.\n\n483Park VT, Grill JD, Zhu J, et al. Asian Americans and Pacific Islanders' perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research. Alzheimers Dement (N Y). 2021; 7(1):e12195.\n\n484Portacolone E, Palmer NR, Lichtenberg P, et al. Earning the Trust of African American Communities to Increase Representation in Dementia Research. Ethn Dis. 2020; 30(Suppl 2): 719-734.\n\n485Liu J, Lou Y, Wu B, Mui A. \"I've been always strong to conquer any suffering:\" challenges and resilience of Chinese American dementia caregivers in a life course perspective. Aging Ment Health. 2021; 25(9): 1716-1724.\n\n486Bonds K, Song MK, Whitlatch CJ, Lyons KS, Kaye JA, Lee CS. Patterns of Dyadic Appraisal of Decision-Making Involvement of African American Persons Living With Dementia. Gerontologist. 2021; 61(3): 383-391.\n\n487Epps F, Alexander K, Brewster GS, et al. Promoting dementia awareness in African-American faith communities. Public Health Nurs. 2020; 37(5): 715-721.\n\n488Racine L, Ford H, Johnson L, Fowler-Kerry S. An integrative review of Indigenous informal caregiving in the context of dementia care. J Adv Nurs. 2022; 78(4): 895-917.\n\n489Epps F, Moore M, Chester M, et al. The Alter Program: A nurse-led, dementia-friendly program for African American faith communities and families living with dementia. Nurs Adm Q. 2021; 46(1): 72-80.\n\n490Freedman VA, Patterson SE, Cornman JC, Wolff JL. A day in the life of caregivers to older adults with and without dementia: Comparisons of care time and emotional health. Alzheimers Dement. 2022; 18(9): 1650-1661.\n\n491 National Alliance for Caregiving and AARP. Caregiving in the U.S. (2015 Report). Accessed December 15, 2023. Available at: https://www.aarp.org/content/dam/aarp/ppi/2015/caregiving-in-the-united-states-2015-report-revised.pdf\n\n492Spillman BC, Freedman VA, Kasper JD, Wolff JL. Change over time in caregiving networks for older adults with and without dementia. J Gerontol B Psychol Sci Soc Sci. 2020; 75(7): 1563-1572.\n\n493Port CL, Zimmerman S, Williams CS, Dobbs D, Preisser JS, Williams SW. Families filling the gap: Comparing family involvement for assisted living and nursing home residents with dementia. Gerontologist. 2005; 45(Special Issue 1): 87-95.\n\n494Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S. Long-term care placement of dementia patients and caregiver health and well-being. JAMA. 2004; 292(8): 961-967.\n\n495Rattinger GB, Schwartz S, Mullins CD, et al. Dementia severity and the longitudinal costs of informal care in the Cache County population. Alzheimers Dement. 2015; 11(8): 946-954.\n\n496Rattinger GB, Fauth EB, Behrens S, et al. Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study. Alzheimers Dement. 2016; 12(8): 917-924.\n\n497Song M-K, Paul S, Happ MB, Lea J, Pirkle JL, Jr., Turberville-Trujillo L. Informal Caregiving Networks of Older Adults With Dementia Superimposed on Multimorbidity: A Social Network Analysis Study. Innov Aging. 2023; 7(4):igad033.\n\n498Wolff JL, Mulcahy J, Huang J, Roth DL, Covinsky K, Kasper JD. Family Caregivers of Older Adults, 1999-2015: Trends in characteristics, circumstances, and role-related appraisal. Gerontologist. 2018; 58(6): 1021-1032.\n\n499Jutkowitz E, Gaugler JE, Trivedi AN, Mitchell LL, Gozalo P. Family caregiving in the community up to 8-years after onset of dementia. BMC Geriatr. 2020; 20(1): 216.\n\n500Gaugler JE, Zarit SH, Pearlin LI. The onset of dementia caregiving and its longitudinal implications. Psychol Aging. 2003; 18(2): 171-180.\n\n501Jutkowitz E, Gozalo P, Trivedi A, Mitchell L, Gaugler JE. The effect of physical and cognitive impairments on caregiving. Med Care. 2020; 58(7): 601-609.\n\n502Lei L, Maust DT, Leggett AN. Functional decline over time and change in family and other unpaid care provided to community-dwelling older adults living with and without dementia. J Gerontol B Psychol Sci Soc Sci. 2023; 78(10): 1727-1734.\n\n503Ornstein K, Gaugler JE. The problem with “problem behaviors”: A systematic review of the association between individual patient behavioral and psychological symptoms and caregiver depression and burden within the dementia patient-caregiver dyad. Int Psychogeriatr. 2012; 24(10): 1536-1552.\n\n504Vaingankar JA, Chong SA, Abdin E, et al. Psychiatric morbidity and its correlates among informal caregivers of older adults. Compr Psychiatry. 2016; 68: 178-185.\n\n505Feast A, Moniz-Cook E, Stoner C, Charlesworth G, Orrell M. A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being. Int Psychogeriatr. 2016; 28(11): 1761-1774.\n\n506Schulz R, Beach SR. Caregiving as a risk factor for mortality: The Caregiver Health Effects Study. JAMA. 1999; 282: 2215-2260.\n\n507Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull. 2003; 129(6): 946-972.\n\n508Liu W, Gallagher-Thompson D. Impact of dementia caregiving: Risks, strains, and growth. In: SH Qualls, SH Zarit, eds. Aging families and caregiving. Hoboken, NJ: John Wiley & Sons, Inc.; 2009: p. 85-112.\n\n509Pinquart M, Sörensen S. Associations of stressors and uplifts of caregiving with caregiver burden and depressive mood: A meta-analysis. J Gerontol B Psychol Sci Soc Sci. 2003; 58(2): 112-128.\n\n510Sörensen S, Duberstein P, Gill D, Pinquart M. Dementia care: Mental health effects, intervention strategies, and clinical implications. Lancet Neurol. 2006; 5(11): 961-973.\n\n511Goren A, Montgomery W, Kahle-Wrobleski K, Nakamura T, Ueda K. Impact of caring for persons with Alzheimer's disease or dementia on caregivers’ health outcomes: Findings from a community based survey in Japan. BMC Geriatr. 2016; 16: 122.\n\n512 Alzheimer's Association. 2016 Alzheimer's Disease Facts and Figures. Alzheimer Dement. 2016; 12(4): 459-509.\n\n513Jones RW, Lebrec J, Kahle-Wrobleski K, et al. Disease progression in mild dementia due to Alzheimer disease in an 18-month observational study (GERAS): The impact on costs and caregiver outcomes. Dement Geriatr Cogn Dis Extra. 2017; 20;7(1): 87-100.\n\n514Leggett AN, Meyer OL, Bugajsky BC, Polenick CA. Accentuate the Positive: The association between informal and formal supports and caregiving gains. J Appl Gerontol. 2021l; 40(7): 763-771.\n\n515Quinn C, Toms G. Influence of positive aspects of dementia caregiving on caregivers' well-being: A systematic review. Gerontologist. 2019; 59(5): e584-e596.\n\n516Zarit SH. Positive aspects of caregiving: More than looking on the bright side. Aging Ment Health. 2012; 16(6): 673-674.\n\n517Cheng ST, Mak EP, Lau RW, Ng NS, Lam LC. Voices of Alzheimer caregivers on positive aspects of caregiving. Gerontologist. 2016; 56(3): 451-460.\n\n518Monin JK, Schulz R, Feeney BC. Com"
    }
}